These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9056160)

  • 21. Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools.
    Adami S; Bertoldo F; Gatti D; Minisola G; Rossini M; Sinigaglia L; Varenna M
    Calcif Tissue Int; 2013 Sep; 93(3):195-200. PubMed ID: 23754490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.
    Gu T; Eisenberg Lawrence DF; Stephenson JJ; Yu J
    Clin Interv Aging; 2016; 11():1-8. PubMed ID: 26929609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in the pharmacotherapy of osteoporosis].
    Kocián J
    Vnitr Lek; 1995 Mar; 41(3):207-9. PubMed ID: 7762183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment osteoporosis 1999].
    Kocián J
    Vnitr Lek; 2000 Jun; 46(6):365-7. PubMed ID: 15645845
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of the glucocorticoids-induced osteoporosis: recent knowledge].
    De Marino AV; Lisi S; Sisto M; D'Amore M
    Recenti Prog Med; 2010 Sep; 101(9):330-2. PubMed ID: 21268369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoride and the treatment of osteoporosis.
    Lancet; 1984 Mar; 1(8376):547. PubMed ID: 6142260
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerostin Inhibition in the Management of Osteoporosis.
    Appelman-Dijkstra NM; Papapoulos SE
    Calcif Tissue Int; 2016 Apr; 98(4):370-80. PubMed ID: 27016922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [RGD-peptides. Integrins. Desintegrins in osteoporosis treatment].
    Petrovich IuA; Gurin NA; Gurin AN; Kichenko SM
    Patol Fiziol Eksp Ter; 2009; (2):37-40, inside back cover. PubMed ID: 19537088
    [No Abstract]   [Full Text] [Related]  

  • 30. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal salmon calcitonin in osteoporosis.
    Overgaard K; Riis BJ
    Calcif Tissue Int; 1994 Aug; 55(2):79-81. PubMed ID: 7953983
    [No Abstract]   [Full Text] [Related]  

  • 32. Osteoporosis in 2017: Addressing the crisis in the treatment of osteoporosis.
    Roux C; Briot K
    Nat Rev Rheumatol; 2018 Feb; 14(2):67-68. PubMed ID: 29323345
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fluorine for osteoporosis].
    Frey H
    Tidsskr Nor Laegeforen; 1970 Sep; 90(17):1638-40. PubMed ID: 5456628
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcitonin.
    Silverman SL
    Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoride treatment in corticosteroid induced osteoporosis.
    Rejou F; Dumas R; Belon C; Meunier PJ; Edouard C
    Arch Dis Child; 1986 Dec; 61(12):1230-1. PubMed ID: 3813618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nutrition in prevention and treatment of osteoporosis].
    Grajeta H
    Przegl Lek; 2003; 60(10):649-53. PubMed ID: 15052727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis. Part IV -- rapid review of drug therapies (A to Z) for preventing male osteoporosis/fractures.
    Secrist J
    Urol Nurs; 2003 Apr; 23(2):168-74. PubMed ID: 12778834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of osteoporosis with vitamin K2].
    Shiraki M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():404-9. PubMed ID: 15035160
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonate use in conditions other than osteoporosis.
    Silverman SL
    Ann N Y Acad Sci; 2011 Feb; 1218():33-7. PubMed ID: 20946575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.